
   experiences hgh treatment twelve hypopituitary 
dwarfs periods varying 6 41 months 
reported.  patients considered 
hypopituitarism birth, four hereditary 
type, four possibly due traumatic birth neonatal asphyxia, 
four unknown cause.  six 
patients detailed information concerning growth 
first year life obtained.  patients 
degree growth retardation one 
year age.  consider rule rather 
exception pituitary dwarfism.  important 
diagnostic evidence marked degree growth retardation 
accompanied pronounced delay skeletal 
maturation, and, cases, signs secondary 
hypothyroidism, increased insulin sensitivity, 
poor response metopyrone administration.  none 
patients passed normal age puberty 
maturated sexually.  twelve patients responded 
well hgh therapy.  first year treatment 
average height increment 10 cm. ('catch-up' growth). 
continued treatment normal rate 
growth, 6 cm./year, obtained.  
disproportionate acceleration skeletal maturation 
patients.  none far become resistant 
hgh administration.  oldest patient 
reached normal height.  whether will possible 
moderately severe, also 
severe cases pituitary dwarfism, can yet stated. 
possibility using human gonadotrophic hormones 
attempt produce sexual maturation 
patients discussed briefly. 
